References
- Hasselgren G, Lind T, Lundell L, Aadland E, Efskind P, Falk A. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebocontrolled multicenter study. Scand J Gastroenterol 1997; 32: 328–333
- Schaffalitzky de Muckadell OB, Havelund T, Harling H, Boesby S, Snel P, Vreeburg EM. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. A randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol 1997; 32: 320–327
- Daneshmend TK, Hawkey CJ, Langman MJS, Logan RFA, Long RG, Walt RP. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. Br Med J 1992; 304: 143–7
- Jaramillo JL, Gálvez C, Carmona C, Montero JL, Miño G. Prediction of further hemorrhage in bleeding peptic ulcer. Am J Gastroenterol 1994; 89: 2135–8
- Swain CP, Storey DW, Brown SG, Heath J, Mills TN, Salmon PR. Nature of the bleeding vessel in recurrently bleeding gastric ulcers. Gastroenterology 1986; 90: 595–608
- Merki HS, Wilder-Smith CH. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing. Gastroenterology 1994; 106: 60–4
- Kiilerich S, Rannem T, Elsborg L. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer. Digestion 1995; 56: 25–30
- Berstad A, Holm HA, Kittang E. Experience with antipeptic agents. Scand J Gastroenterol 1979; 14: 121–3, Suppl 55
- Berstad A. Pepsin secretion. Clinical investigation of gastric function. Front Gastrointest Res, C Scarpignato, G Bianchi Porro, 1990; 17: 95–102
- Berstad A, Almodovar K, Berstad K, Anderson W, Hirschowitz BI. Effect of tranexamic acid on gastric bleeding in rats. Scand J Gastroenterol 1988; 23: 402–6
- Staël von Holstein CCS, Eriksson SBS, Källén R. Tranexamic acid in gastric and duodenal bleeding. Br Med J 1987; 294: 7–10
- Johannesen K-A, Nordrehaug JE, Lippe von der G. Left ventricular thrombosis and cerebrovascular accident in acute myocardial infarction. Br Heart J 1984; 51: 553–6
- Yamamoto O, Matsunaga Y, Haga N, Mizumoto A, Itoh Z. Inhibition of phase III activity by acidifying the stomach in vagally denervated and innervated dogs with gastric pouches. Gastroenterology 1994; 106: 1533–41
- Kusano M, Sekiguchi T, Nishioka T, Kawamura O, Kikuchi K, Matsuzaki T. Gastric acid inhibits antral phase III activity in duodenal ulcer patients. Dig Dis Sci 1993; 38: 824–31
- Wilder-Smith CH, Merki HS. Tolerance during dosing with H2-receptor antagonists. An overview. Scand J Gastroenterol 1992; 27: 14–9, Suppl 193